Go to the list of all blogs
Allana's Avatar
published in Blogs
Sep 24, 2026
Why Is Gildan Activewear (GIL) Stock Down -11.82% Today?

Why Is Gildan Activewear (GIL) Stock Down -11.82% Today?

Key Takeaways

  • GIL shares tumbled roughly 11.82% to $40.73, down $5.46 from the prior session's close of $46.19.
  • The primary catalyst was a steep price-target cut from TD Securities, which lowered its target to $54 from $80.
  • The analyst cited softening demand across activewear and retail channels, pressured by rising bond yields and higher gas prices.
  • Trading volume surged to multiples of the stock's average, signaling heavy institutional repositioning.
  • Investors are now watching for stabilization near the 52-week low and any signs of demand recovery heading into the holiday season.

Opening Summary

Gildan Activewear Inc. (GIL), the Montreal-based manufacturer of basic apparel, activewear, socks, and underwear sold under brands including Gildan, American Apparel, and Comfort Colors, saw its shares plunge sharply on Wednesday. The stock fell about 11.82%, closing the session near $40.73 versus a prior close of $46.19. The decline was driven primarily by a significant downgrade of expectations from sell-side analysts, who pointed to weakening demand across the activewear and retail landscape.

Analyst Target Cut Weighs on Sentiment

The most direct catalyst behind the selloff was a decision by TD Securities to slash its price target on GIL to $54 from $80, even while maintaining a Buy rating. The firm argued that industry demand across both activewear and retail channels has softened since the company's second-quarter earnings release, as surging bond yields and escalating gas prices weigh on discretionary consumer spending. For a stock already trading well below its 52-week high, the abrupt reset in the analyst's valuation framework was enough to trigger a wave of selling.

Softer Consumer Demand and Macro Pressures

Beyond the single rating action, the move reflects a broader concern about the health of the consumer. Rising interest rates and higher fuel costs tend to squeeze household budgets, and basic apparel makers are not immune. Gildan's wholesale and retail partners have shown signs of more cautious ordering patterns, a dynamic the analyst community believes could persist into the coming quarters. The company's second-quarter results had already hinted at mixed demand, with revenue of $1.58 billion rising sharply year-over-year but coming in below consensus expectations.

Guidance and Tariff Refund Context

Investors were also digesting Gildan's earlier decision to trim its full-year outlook to the low end of its previously stated $6.0 billion to $6.2 billion revenue range. The company has pointed to approximately $220 million in expected IEEPA tariff refunds during 2026, most of it in the third quarter, but a substantial portion of that benefit is non-recurring. While the recurring portion tied to changes in U.S. tariff policy supports the outlook, the one-time nature of much of the refund has limited its ability to offset broader demand concerns.

Market Context and Trading Activity

The selloff was accompanied by unusually heavy volume, with trading activity running several times the stock's average daily turnover. The decline pushed GIL toward the lower end of its recent range and within striking distance of its 52-week low, with the shares trading well below both their 50-day and 200-day moving averages. The move stands out relative to the broader market, indicating that the pressure on the name was company- and sector-specific rather than a broad risk-off event, though lingering macro headwinds around yields and energy costs added to the bearish tone.

What Comes Next for GIL

Looking ahead, traders will be watching whether GIL can find support near its recent lows and whether retailer commentary during the upcoming earnings season confirms or contradicts the demand concerns raised by analysts. The company's tariff-refund tailwinds and vertically integrated, cost-efficient manufacturing footprint remain supportive factors, but the immediate focus is on the trajectory of consumer spending and any further revisions to guidance. A lack of clarity around demand trends, combined with the ongoing overhang from the analyst target cut, leaves the stock vulnerable to continued volatility in the near term.

Trending AI Robots

For traders seeking a data-driven approach to navigating volatile names like GIL, Tickeron's Trending AI Robots page offers a curated look at its top-performing automated strategies. Tickeron provides hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving investors a range of tools to explore. Consider reviewing the page to see which AI-driven approaches are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: GIL

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


GIL in downward trend: price dove below 50-day moving average on September 04, 2026

GIL moved below its 50-day moving average on September 04, 2026 date and that indicates a change from an upward trend to a downward trend. In 28 of 41 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 68%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GIL as a result. In 57 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for GIL turned negative on August 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 30 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

The 10-day moving average for GIL crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GIL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for GIL entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GIL's RSI Oscillator exited the oversold zone, 21 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 70%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where GIL advanced for three days, in 207 of 323 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

GIL may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.561) is normal, around the industry mean (6.113). P/E Ratio (35.806) is within average values for comparable stocks, (28.757). Projected Growth (PEG Ratio) (0.385) is also within normal values, averaging (0.694). Dividend Yield (0.021) settles around the average of (0.017) among similar stocks. GIL's P/S Ratio (1.662) is slightly higher than the industry average of (0.827).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GIL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. GIL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are VF Corp (NYSE:VFC), G-III Apparel Group Ltd (NASDAQ:GIII), Canada Goose Holdings (NYSE:GOOS), Lakeland Industries (NASDAQ:LAKE).

Industry description

Apparel/footwear might be slightly more ‘cyclical’ in the largely non-cyclical category of non-durables. While digital giants like Amazon have been rapidly expanding their presence, traditional clothing/footwear retailers have also been bulking up their online presence in recent years, to milk the burgeoning trend of online shopping among consumers across the globe. The apparel and footwear retail market was valued at around $ 360 billion in 2018, and this figure was expected to reach about $386 billion by 2020 (according to a Statista report). NIKE, Inc, V.F. Corporation and Under Armour, Inc. are some of the companies with the largest U.S. stock market caps in this segment.

Market Cap

The average market capitalization across the Apparel/Footwear Industry is 2.72B. The market cap for tickers in the group ranges from 1.66K to 27.24B. HNNMY holds the highest valuation in this group at 27.24B. The lowest valued company is SQBGQ at 1.66K.

High and low price notable news

The average weekly price growth across all stocks in the Apparel/Footwear Industry was 0%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 18%. VNCE experienced the highest price growth at 29%, while OXM experienced the biggest fall at -10%.

Volume

The average weekly volume growth across all stocks in the Apparel/Footwear Industry was 4%. For the same stocks of the Industry, the average monthly volume growth was 21% and the average quarterly volume growth was 8%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 54
Price Growth Rating: 62
SMR Rating: 72
Profit Risk Rating: 93
Seasonality Score: -9 (-100 ... +100)
View a ticker or compare two or three
GIL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of branded apparel

Industry ApparelFootwear

Industry
Apparel Or Footwear
Address
600 de Maisonneuve Boulevard West
Phone
+1 514 735-2023
Employees
80000
Web
https://www.gildancorp.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.